Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. company information, Employees & Contact Information

INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our mission: deliver on the promise of DNA medicine for patients around the world. For more information, visit www.inovio.com.
Looking for a particular Inovio Pharmaceuticals, Inc. employee's phone or email?

Inovio Pharmaceuticals, Inc. Questions

News

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 - Morningstar

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 Morningstar

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference PR Newswire

INOVIO (NASDAQ: INO) sets Nov. 10 results call for 4:30 p.m. ET with live webcast and Q&A - Stock Titan

INOVIO (NASDAQ: INO) sets Nov. 10 results call for 4:30 p.m. ET with live webcast and Q&A Stock Titan

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults - PR Newswire

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults PR Newswire

Biotech INOVIO Awards New Employee Stock Options Worth $2.34 Per Share Under Inducement Plan - Stock Titan

Biotech INOVIO Awards New Employee Stock Options Worth $2.34 Per Share Under Inducement Plan Stock Titan

INOVIO Reports Inducement Grant Under Inducement Plan - Sahm

INOVIO Reports Inducement Grant Under Inducement Plan Sahm

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Morningstar

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights Morningstar

INOVIO to Participate in Upcoming Scientific Conferences - PR Newswire

INOVIO to Participate in Upcoming Scientific Conferences PR Newswire

INOVIO to Present at Upcoming Scientific Conference - PR Newswire

INOVIO to Present at Upcoming Scientific Conference PR Newswire

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights PR Newswire

INOVIO Announces Pricing of $25 Million Public Offering - Yahoo Finance

INOVIO Announces Pricing of $25 Million Public Offering Yahoo Finance

Leading DNA Medicine Developer INOVIO to Showcase Pipeline at Major Healthcare Investment Conference - Stock Titan

Leading DNA Medicine Developer INOVIO to Showcase Pipeline at Major Healthcare Investment Conference Stock Titan

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025 - Eastern Progress

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025 Eastern Progress

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - PR Newswire

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights PR Newswire

DNA Medicine Breakthrough: INOVIO's INO-3107 Shows Long-Term Efficacy in Rare Respiratory Disease Treatment - Stock Titan

DNA Medicine Breakthrough: INOVIO's INO-3107 Shows Long-Term Efficacy in Rare Respiratory Disease Treatment Stock Titan

INOVIO's RRP Treatment Shows 86% Response Rate as Company Readies FDA Filing - Stock Titan

INOVIO's RRP Treatment Shows 86% Response Rate as Company Readies FDA Filing Stock Titan

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 - PR Newswire

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 PR Newswire

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments - PR Newswire

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments PR Newswire

INOVIO Reveals Breakthrough: DNA Therapy INO-3107 Cuts RRP Surgeries by 81% - First Long-Term Data - Stock Titan

INOVIO Reveals Breakthrough: DNA Therapy INO-3107 Cuts RRP Surgeries by 81% - First Long-Term Data Stock Titan

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions - Yahoo Finance

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions Yahoo Finance

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa - CEPI

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa CEPI

IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO's COVID-19 DNA vaccine in South Korea - CEPI

IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO's COVID-19 DNA vaccine in South Korea CEPI

CEPI partner Inovio Advances Lassa Fever Candidate Vaccine Into a Clinical Trial - CEPI

CEPI partner Inovio Advances Lassa Fever Candidate Vaccine Into a Clinical Trial CEPI

INOVIO Receives $71 Million Contract From U.S. Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA Vaccine - PR Newswire

INOVIO Receives $71 Million Contract From U.S. Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA Vaccine PR Newswire

Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS - CEPI

Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS CEPI

Inovio Announces Appointments to its Board of Directors - PR Newswire

Inovio Announces Appointments to its Board of Directors PR Newswire

Inovio Pharmaceuticals Announces Reverse Stock Split Date - PR Newswire

Inovio Pharmaceuticals Announces Reverse Stock Split Date PR Newswire

Top Inovio Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant